Article
Establishment of the induced pluripotent stem cell line PLAFMCi006-A from peripheral blood mononuclear cells of polycystic kidney disease patients with PKD2 gene mutation.
Stem cell research - 1 Apr 2022
Ma Yuxiang, Shang Shunlai, Shi Meihan, Yang Yunzhao, Li Qinggang, Bai Xue-Yuan
Abstract excerpt
Polycystic kidney disease (PKD) caused by PKD2 mutation is an important type of autosomal dominant PKD. In this study, peripheral blood mononuclear cells from a patient with PKD2 polycystic kidney disease were reprogrammed to obtain induced pluripotent stem cells (iPSCs). After stable amplification, the pluripotency of the iPSCs was determined by identifying their cell-surface markers, their expression of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
